Skip to main content
Top
Published in: European Archives of Psychiatry and Clinical Neuroscience 4/2017

01-06-2017 | Original Paper

Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)

Authors: José María Pelayo-Terán, Virginia Gajardo Gajardo Galán, Víctor de la Ortiz-García de la Foz, Obdulia Martínez-García, Rafael Tabarés-Seisdedos, Benedicto Crespo-Facorro, Rosa Ayesa-Arriola

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 4/2017

Login to get access

Abstract

Relapses may represent a critical hazard in schizophrenia spectrum disorders as they are associated with an increased risk of a clinical and functional deterioration. Preventing relapse after recovering from a first psychotic episode has become a major challenge due to its critical impact on lifelong functionality. This study explored the rate of first and second relapses and the predictors associated with these relapses in a large cohort of non-affective psychosis patients during a period of 3 years after the first break of the illness. From February 2001 to May 2014, sociodemographic and clinical data from an epidemiological cohort of 341 non-affective first-episode psychosis patients at risk of relapse were analysed at a specialized early intervention service. Logistic regression, Cox regression, and Kaplan–Meier survival analyses were performed to compare non-relapsed and relapsed patients. One hundred and sixty-six (48.7%) individuals relapsed at least once. Median time to relapse was 17.0 months in non-adherent patients and 40.0 months in adherent patients (log-rankχ 2: 51.36; p < 0.001). Non-adherence to medication (odds ratio-OR 2.979; p < 0.001), schizophrenia diagnosis (OR 2.173; p = 0.002), and age of onset (OR 1.020; p = 0.033) were the main predictors of the first relapse. Fifty-six subjects experienced a second relapse (33.73%) predicted by diagnosis (OR 1.975; p = 0.074), age of onset (OR 1.078; p = 0.003), and positive symptoms (OR 0.863; p = 0.03), but not adherence. Non-adherence is the main predictive factor of first relapse after a first episode of psychosis. Second relapses were not often and not related to modifiable factors, suggesting that multiple relapsed patients may comprise a subgroup with a higher biological risk.
Literature
1.
go back to reference Kane JM (2007) Treatment strategies to prevent relapse and encourage remission. J Clin Psychiatry 68(Suppl 1):27–30PubMed Kane JM (2007) Treatment strategies to prevent relapse and encourage remission. J Clin Psychiatry 68(Suppl 1):27–30PubMed
2.
go back to reference Wyatt RJ (1997) Research in schizophrenia and the discontinuation of antipsychotic medications. Schizophr Bull 23:3–9CrossRefPubMed Wyatt RJ (1997) Research in schizophrenia and the discontinuation of antipsychotic medications. Schizophr Bull 23:3–9CrossRefPubMed
3.
go back to reference Wiersma D, Nienhuis FJ, Slooff CJ, Giel R (1998) Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 24:75–85CrossRefPubMed Wiersma D, Nienhuis FJ, Slooff CJ, Giel R (1998) Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr Bull 24:75–85CrossRefPubMed
4.
go back to reference Lieberman J, Jody D, Geisler S et al (1993) Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 50:369–376CrossRefPubMed Lieberman J, Jody D, Geisler S et al (1993) Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 50:369–376CrossRefPubMed
14.
go back to reference Birchwood M, Todd P, Jackson C (1998) Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl 172:53–59CrossRefPubMed Birchwood M, Todd P, Jackson C (1998) Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl 172:53–59CrossRefPubMed
15.
go back to reference Mayoral-van Son J, de la Foz VO-G, Martinez-Garcia O et al (2015) Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals. J Clin Psychiatry. doi:10.4088/JCP.14m09540 Mayoral-van Son J, de la Foz VO-G, Martinez-Garcia O et al (2015) Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals. J Clin Psychiatry. doi:10.​4088/​JCP.​14m09540
17.
go back to reference Pelayo-Terán JM, Pérez-Iglesias R, Ramírez-Bonilla M et al (2008) Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis. Early Interv Psychiatry 2:178–187. doi:10.1111/j.1751-7893.2008.00074.x CrossRefPubMed Pelayo-Terán JM, Pérez-Iglesias R, Ramírez-Bonilla M et al (2008) Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis. Early Interv Psychiatry 2:178–187. doi:10.​1111/​j.​1751-7893.​2008.​00074.​x CrossRefPubMed
18.
go back to reference Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M et al (2006) A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. J Clin Psychiatry 67:1511–1521. doi:10.4088/JCP.v67n1004 CrossRefPubMed Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M et al (2006) A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. J Clin Psychiatry 67:1511–1521. doi:10.​4088/​JCP.​v67n1004 CrossRefPubMed
19.
go back to reference First MB, Spitzer RL, Gibbon M, Williams JBW (2001) Structured Clinical Interview for DSM-IV Axis I disorders (clinician version). New York State Psychiatric Institute Biometrics Department, New York First MB, Spitzer RL, Gibbon M, Williams JBW (2001) Structured Clinical Interview for DSM-IV Axis I disorders (clinician version). New York State Psychiatric Institute Biometrics Department, New York
20.
go back to reference Guy W (1976) CGI. Clinical global impression. In: Guy W (ed) ECDEU assess. Man. Psychopharmacol. Revis, pp 217–222 Guy W (1976) CGI. Clinical global impression. In: Guy W (ed) ECDEU assess. Man. Psychopharmacol. Revis, pp 217–222
22.
go back to reference Andreasen NC (1984) Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, Iowa City Andreasen NC (1984) Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, Iowa City
23.
go back to reference Andreasen NC (1983) Scale for the Assessment of Negative Symptoms (SANS). University of Iowa, Iowa Andreasen NC (1983) Scale for the Assessment of Negative Symptoms (SANS). University of Iowa, Iowa
24.
go back to reference Addington D, Addington J, Maticka-Tyndale E (1993) Assessing depression in schizophrenia: The Calgary depression scale. Br J Psychiatry 22:39–44 Addington D, Addington J, Maticka-Tyndale E (1993) Assessing depression in schizophrenia: The Calgary depression scale. Br J Psychiatry 22:39–44
25.
go back to reference Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435CrossRefPubMed Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435CrossRefPubMed
26.
go back to reference Crespo-Facorro B, Pérez-Iglesias R, Mata I et al (2011) Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine. J Psychiatr Res 45:763–769. doi:10.1016/j.jpsychires.2010.11.002 CrossRefPubMed Crespo-Facorro B, Pérez-Iglesias R, Mata I et al (2011) Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine. J Psychiatr Res 45:763–769. doi:10.​1016/​j.​jpsychires.​2010.​11.​002 CrossRefPubMed
27.
go back to reference Hollingshead A, Redlich F (1958) Social class and mental illness: a community study. Wiley, New YorkCrossRef Hollingshead A, Redlich F (1958) Social class and mental illness: a community study. Wiley, New YorkCrossRef
28.
go back to reference Amador XF, Flaum M, Andreasen NC et al (1994) Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry 51:826–836CrossRefPubMed Amador XF, Flaum M, Andreasen NC et al (1994) Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry 51:826–836CrossRefPubMed
29.
go back to reference Cannon-Spoor HE, Potkin SG, Wyatt RJ (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8:470–484CrossRefPubMed Cannon-Spoor HE, Potkin SG, Wyatt RJ (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8:470–484CrossRefPubMed
30.
go back to reference van Mastrigt S, Addington J (2002) Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale. J Psychiatry Neurosci 27:92–101PubMedPubMedCentral van Mastrigt S, Addington J (2002) Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale. J Psychiatry Neurosci 27:92–101PubMedPubMedCentral
31.
go back to reference Robinson DG, Woerner MG, Alvir JM et al (1999) Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 156:544–549CrossRefPubMed Robinson DG, Woerner MG, Alvir JM et al (1999) Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 156:544–549CrossRefPubMed
32.
34.
go back to reference Coldham EL, Addington J, Addington D (2002) Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 106:286–290CrossRefPubMed Coldham EL, Addington J, Addington D (2002) Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 106:286–290CrossRefPubMed
37.
go back to reference Wunderink L, Nienhuis FJ, Sytema S et al (2007) Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. J Clin Psychiatry 68:654–656. doi:10.4088/JCP.v68n0502 CrossRefPubMed Wunderink L, Nienhuis FJ, Sytema S et al (2007) Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. J Clin Psychiatry 68:654–656. doi:10.​4088/​JCP.​v68n0502 CrossRefPubMed
38.
Metadata
Title
Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)
Authors
José María Pelayo-Terán
Virginia Gajardo Gajardo Galán
Víctor de la Ortiz-García de la Foz
Obdulia Martínez-García
Rafael Tabarés-Seisdedos
Benedicto Crespo-Facorro
Rosa Ayesa-Arriola
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 4/2017
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-016-0740-3

Other articles of this Issue 4/2017

European Archives of Psychiatry and Clinical Neuroscience 4/2017 Go to the issue